Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
In the last 90 days, Protara Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.2M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Protara Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $882.2K in total
- Insiders trading
- 1
- Net value
- −$882.2K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Protara Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Shefferman Jesse | CEO and President | 691,832 | Jul 1, 2026 | 4 |
| Beshar Luke M | Director | 198,000 | Jun 16, 2026 | 1 |
| Sargen Gregory | Director | – | Jun 16, 2026 | 1 |
| Garceau Roger | Director | – | Jun 16, 2026 | 1 |
| Levy Richard S | Director | 51,000 | Jun 16, 2026 | 1 |
| Smith Cynthia | Director | – | Jun 16, 2026 | 1 |
| Flannelly Barry P | Director | – | Jun 16, 2026 | 1 |
| Huang Jane | Director | – | Jun 16, 2026 | 1 |
| Solomon Michael Edward | Director | – | Jun 16, 2026 | 1 |
| Conkling William | Chief Commercial Officer | 69,992 | Jun 3, 2026 | 2 |
| Zummo Jacqueline | Chief R&D Officer | 94,827 | Apr 9, 2026 | 5 |
| Fabbio Patrick | Chief Financial Officer | 64,115 | Jan 27, 2026 | 3 |
| Fry Hannah | VP, Controller | 42,723 | Jan 27, 2026 | 3 |
| Nicacio Leonardo Viana | Chief Medical Officer | 78,181 | Jan 21, 2026 | 1 |
| Opaleye Management Inc. | 10% Owner | 45,000Indirect | Sep 12, 2024 | 0 |
| Bandari Jathin | Chief Medical Officer | 56,704 | Jan 23, 2024 | 0 |
| Davis Blaine | Chief Financial Officer | 20,662 | Jul 19, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 (view filing)4:10 PM ET | Jun 29 | 2 days | Shefferman JesseCEO and President | SSale | −215.7K | $4.09 | −$882.2K | −23.0%721.8K after | |
| Apr 9, 2026 (view filing) | Apr 8 | 1 day | Zummo JacquelineChief R&D Officer | SSale | −1.13K | $5.40 | −$6.12K | −1.2%94.8K after | |
| Apr 2, 2026 (view filing) | Apr 1 | 1 day | Zummo JacquelineChief R&D Officer | SSale | −22.6K | $5.26 | −$118.9K | −19.1%96.0K after | |
| May 19, 2025 (view filing) | May 14 | 5 days | Levy Richard SDirector | PPurchase | +20.0K | $3.19 | +$63.8K | +64.5%51.0K after | Amended |
| Mar 28, 2025 (view filing) | Mar 26 | 2 days | Zummo JacquelineChf Scientific Operations Off | SSale | −21.2K | $4.53 | −$96.1K | −17.7%98.9K after | 10b5-1 |
| Sep 12, 2024 (view filing) | Sep 11-12 | 1 day | Opaleye Management Inc.10% Owner | SSaleCommon Stock, par value $0.001 per share | −158.9K | $1.71 | −$271.7K | −77.9%45.0K after | 4 lots |
| Sep 10, 2024 (view filing) | Sep 9-10 | 1 day | Opaleye Management Inc.10% Owner | SSaleCommon Stock, par value $0.001 per share | −62.0K | $1.84 | −$114.1K | −53.9%53.1K after | 4 lots |
| Jul 18, 2024 (view filing) | Jul 16 | 2 days | Opaleye Management Inc.10% Owner | SSaleCommon Stock, par value $0.001 per share | −11.4K | $2.44 | −$27.8K | −16.8%56.5K after | 2 lots |
| Jul 11, 2024 (view filing) | Jul 9-11 | 2 days | Opaleye Management Inc.10% Owner | SSaleCommon Stock, par value $0.001 per share | −74.6K | $2.36 | −$175.7K | −55.4%60.0K after | 6 lots |
| Jul 3, 2024 (view filing) | Jul 1 | 2 days | Opaleye Management Inc.10% Owner | SSaleCommon Stock, par value $0.001 per share | −8.29K | $2.12 | −$17.6K | −8.7%87.5K after | 2 lots |
| Jun 28, 2024 (view filing) | Jun 27-28 | 1 day | Opaleye Management Inc.10% Owner | SSaleCommon Stock, par value $0.001 per share | −64.6K | $2.21 | −$142.5K | −43.2%85.0K after | 4 lots |
| Jun 27, 2024 (view filing) | Jun 25 | 2 days | Opaleye Management Inc.10% Owner | SSaleCommon Stock, par value $0.001 per share | −12.7K | $2.26 | −$28.8K | −11.0%102.5K after | 2 lots |
| May 31, 2024 (view filing) | May 30-31 | 1 day | Opaleye Management Inc.10% Owner | SSaleCommon Stock, par value $0.001 per share | −15.1K | $2.92 | −$44.0K | −12.2%108.7K after | 2 lots |
| May 23, 2024 (view filing) | May 21-22 | 2 days | Opaleye Management Inc.10% Owner | SSaleCommon Stock, par value $0.001 per share | −42.8K | $3.05 | −$130.6K | −25.7%123.8K after | 4 lots |
| May 17, 2024 (view filing) | May 17 | Same day | Opaleye Management Inc.10% Owner | SSaleCommon Stock, par value $0.001 per share | −70.9K | $3.25 | −$230.4K | −36.0%126.0K after | 4 lots |
| May 10, 2024 (view filing) | May 9-10 | 1 day | Opaleye Management Inc.10% Owner | SSaleCommon Stock, par value $0.001 per share | −182.3K | $3.11 | −$566.3K | −7.1%2.38M after | 2 lots |
| Dec 30, 2022 (view filing) | Dec 30 | Same day | Opaleye Management Inc.10% Owner | SSaleCommon Stock, par value $0.001 per share | +15.5K | $2.71 | +$41.9K | +13.5%130.0K after | 2 lots |
| Sep 15, 2022 (view filing) | Sep 14-15 | 1 day | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +23.9K | $3.93 | +$93.8K | +22.0%132.3K after | 4 lots |
| Aug 15, 2022 (view filing) | Aug 11 | 4 days | Shefferman JesseCEO and President | PPurchase | +9.06K | $3.84 | +$34.8K | +1.0%879.4K after | |
| Jul 5, 2022 (view filing) | Jun 30 | 5 days | Beshar Luke MDirector | PPurchase | +10.0K | $3.10 | +$31.0K | +5.3%198.0K after | |
| Apr 15, 2022 (view filing) | Apr 7-8 | 8 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +10.1K | $4.79 | +$48.5K | +8.6%127.5K after | Amended4 lots |
| Mar 16, 2022 (view filing) | Mar 14 | 2 days | Beshar Luke MDirector | PPurchase | +10.0K | $4.25 | +$42.5K | +5.6%188.0K after | |
| Mar 14, 2022 (view filing) | Mar 10 | 4 days | Beshar Luke MDirector | PPurchase | +10.0K | $4.46 | +$44.6K | +6.0%178.0K after | |
| Jan 31, 2022 (view filing) | Jan 28 | 3 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +24.0K | $4.96 | +$119.2K | +24.0%124.0K after | 2 lots |
| Dec 29, 2021 (view filing) | Dec 28-29 | 1 day | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +11.6K | $6.60 | +$76.5K | +10.7%120.0K after | 3 lots |
| Dec 27, 2021 (view filing) | Dec 23-27 | 4 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +38.0K | $6.53 | +$248.2K | +52.8%110.0K after | 4 lots |
| Dec 22, 2021 (view filing) | Dec 20 | 2 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +703 | $6.49 | +$4.56K | 0.0%2.50M after | |
| Dec 20, 2021 (view filing) | Dec 16-17 | 4 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +10.4K | $6.46 | +$66.9K | +11.0%104.2K after | 4 lots |
| Nov 19, 2021 (view filing) | Nov 17-18 | 2 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +24.3K | $6.98 | +$169.8K | +31.1%102.6K after | 4 lots |
| Nov 8, 2021 (view filing) | Nov 4 | 4 days | Opaleye Management Inc.10% Owner | PPurchaseCommon Stock, par value $0.001 per share | +6.56K | $6.50 | +$42.6K | +7.0%100.6K after | 2 lots |